Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality.
International Journal of Dermatology. 2004 Jan;43(1):63-6.
Baysal V, Yildirim M, Ozcanli C, Ceyhan AM., Department of Dermatology, School of Medicine, University of Suleyman Demirel, Isparta, Turkey.
BACKGROUND: Due to the high rate of recurrence, seborrheic dermatitis (SD) represents a therapeutic problem.
AIM: To evaluate the role of oral itraconazole in the treatment of SD.
PATIENTS AND METHODS: Thirty-two patients with SD were enrolled in the study. All topical and oral treatments were stopped. The patients applied 1% hydrocortisone cream twice daily for 1 month. In addition, they took itraconazole, 200 mg/day, during the first week of the first month and then hydrocortisone cream was stopped and itraconazole (200 mg/day) was given on the first 2 days of the following 11 months. The patients were followed for 2 months without medicine. The severity score was measured at the initial evaluation, and at the first, 12th, and 14th months.
RESULTS: Twenty-eight patients completed the study. There was a statistically significant decrease in the mean severity score at the first, 12th, and 14th months. On the final evaluation at the 12th month, 19 of the 28 patients showed a complete improvement, and three patients showed a slight improvement.
CONCLUSIONS: This study indicates that itraconazole plays an important role in the treatment of SD.
I don’t think many would recommend including the cortisone cream twice daily for 1 month, this may lead to other rosacea related symptoms.
- Rosacea News: seb derm, elidel and protopic : a warning
- Rosacea News: itraconazole and treating seb derm
No comments yet ↓
There are no comments yet. Be the first by filling out the form below.
Leave a Comment